AquaDrugs
Financiado
Uncovering the effects of pharmaceuticals in the wild, beyond individuals to ani...
Uncovering the effects of pharmaceuticals in the wild, beyond individuals to animal communities
The increasing production and release of pharmaceutical pollutants into waterways is now a leading threat to aquatic wildlife and ecosystems around the world. Despite this, knowledge on the hazards these contaminants cause in comp...
The increasing production and release of pharmaceutical pollutants into waterways is now a leading threat to aquatic wildlife and ecosystems around the world. Despite this, knowledge on the hazards these contaminants cause in complex natural ecosystems is still extremely poor and thus considered an urgent research priority. AquaDrugs will harness new developments in underwater animal tracking and computer automation to identify how pharmaceutical waste in the environment can induce behavioural changes in animals that lead to high-order ecological effects. Through a series of well-integrated experiments, and using fish as a model system, AquaDrugs will trace the impact of pharmaceuticals across biological scales to address four novel and ambitious objectives: (1) test how environmentally relevant concentrations of two globally pervasive pharmaceuticals (clobazam an tramadol), both in isolation and in a mixture, influence ecologically important wildlife behaviours and variability; (2) identify whether, and how, such changes impact animal collectives; (3) determine how pharmaceutical-induced behavioural changes at the individual and group levels scale up to shape aquatic communities; and (4) uncover how exposure shapes the ecological interactions of multiple species. The project will deliver urgently needed data for chemicals regulation leading to improved policies that safeguard Europe’s aquatic ecosystems and wildlife from pharmaceutical impacts. The interdisciplinary approaches and theory in AquaDrugs—from integrative ecology, ecotoxicology, and analytical chemistry—also promises to yield pioneering results and experimental innovations that will advance these scientific fields and boost the expertise and academic career of the research fellow, Dr Marcus Michelangeli. Importantly, the research in AquaDrugs directly addresses key research priorities in Europe including the European Green Deal and the EU’s Mission for ‘Healthy Oceans, Seas, and Inland Waters’.
ver más
Duración del proyecto: 24 meses
Fecha Inicio: 2022-12-12
Fecha Fin: 2024-12-31
Fecha Fin: 2024-12-31
Línea de financiación: concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-12-12
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
HORIZON-MSCA-2021-PF-01-01:
MSCA Postdoctoral Fellowships 2021
Cerrada
hace 3 años
Presupuesto
El presupuesto total del proyecto asciende a
223K€
Líder del proyecto
SVERIGES LANTBRUKSUNIVERSITET
No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico
TRL
4-5
Perfil tecnológico
TRL
4-5
N.D. |
Participante